Chemaphor receives first approvals for feed additive patent application
Ottawa, Canada based Chemaphor Inc. has achieved its first successes with acceptances in Australia, New Zealand, South Africa and Russia of its international patent application “Compositions and methods for promoting weight gain and fed conversion”, after entering the National Phase of the Patent Cooperation Treaty (PCT).
Applications are presently pending in other regions of the world, including the US, Europe, Asia and South America.
Dr. Graham Burton, President of Chemaphor, commented “These are significant early milestones in the plan to achieve extensive patent protection for global use of Chemaphor’s proprietary OxC-beta technology for promoting and maintaining optimal health in animals.
“Our scientific studies strongly support OxC-beta achieving this effect by supporting the animals’ immune health. Under the stress of typical food animal production conditions the immune health benefit ultimately can help improve performance of the animals.”
The invention relates to the use of carotenoid oxidation products as non-antibiotic alternatives to promote growth and feed conversion in food animals.
OxC-beta is a concentrated source of oxidized carotenoid, containing oxidation compounds that occur extensively in the plant world.
Results of clinical trials in animals and in vitro studies indicate OxC-beta helps support immune function, which can result in general overall health improvement. Specific benefits include better growth and utilization of feed in poultry and swine.
International patents also have been filed for the use of OxC-beta in enhancing immune function, and for improving health of companion animals and of fish in aquaculture. Two of these applications have entered the National Phase and the third will enter later this year.
Join 26,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the feed sector, three times a week.
